AI-Driven Multimodal Imaging Integration for Diagnosis and Prognostication of Digestive System Diseases
1 other identifier
observational
5,000
1 country
1
Brief Summary
The goal of this observational, retrospective and prospective study is to develop a noninvasive disease assessment system by leveraging artificial intelligence (AI) to comprehensively analyze multi-modal imaging features, including magnetic resonance enterography (MRE) and computed tomography enterography (CTE), for the diagnosis and prognostication of digestive diseases. To this end, the investigators retrospectively enrolled imaging, endoscopic, and clinical data from 21 centers across China to construct and iteratively optimize the AI model. The model's performance will be prospectively validated in two centers, and its accuracy in lesion localization will be verified through real-world deployment in endoscopy suites.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2025
CompletedFirst Submitted
Initial submission to the registry
July 20, 2025
CompletedFirst Posted
Study publicly available on registry
July 28, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2026
April 13, 2026
April 1, 2026
1.1 years
July 20, 2025
April 8, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The area under the ROC curve (AUC) to assess the performance of diagnostic model.
After baseline MR or CT scanning, patients were followed up.
6 months
Interventions
Using the virtual endoscopy model to aid diagnosis
Eligibility Criteria
This retrospective and prospective study included patients with digestive diseases. For the retrospective component, the investigators enrolled patients from 21 hospitals across China, including the First Affiliated Hospital of Sun Yat-sen University. For the prospective component, the investigators enrolled patients from the First Affiliated Hospital of Sun Yat-sen University and the Third Affiliated Hospital of Guangzhou Medical University.
You may qualify if:
- Patients with multimodal-confirmed diagnoses (clinical, imaging, endoscopic, and pathological) of:
- Inflammatory bowel disease (IBD; Crohn's disease or ulcerative colitis)
- Intestinal tuberculosis
- Behçet's disease
- Availability of ≥1 technically adequate CT or MR scan with high-quality colonoscopy performed within ±1 month of imaging.
You may not qualify if:
- ・Suboptimal imaging quality (e.g., low-dose artifacts, metal artifacts)
- Inadequate bowel preparation for endoscopy
- Incomplete examinations due to poor tolerance
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
XploreMET v3.0 system
Shanghai, China
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Xuehua Li
Sun Yat-sen University First Affiliated Hospital Department of Radiology
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- associate chief physician
Study Record Dates
First Submitted
July 20, 2025
First Posted
July 28, 2025
Study Start
July 1, 2025
Primary Completion (Estimated)
August 1, 2026
Study Completion (Estimated)
August 1, 2026
Last Updated
April 13, 2026
Record last verified: 2026-04